Research lines

  • -Anti-CD69.
  • -Anti-Class II MHC
  • -Biosensors using antibodies and nanostructures.
  • -Design of an efficient vaccine using nanomaterials for M. tuberculosis.
  • -Immune profile of response to M. tuberculosis antigens.
  • -Massive transcriptomic in patients and their contacts (infected and non-infected)
  • -Several directed to human B cells and human monocytes.
  • -Standarization of methods to check biocompatibility, toxicity and immunogenicity of nanoparticles.
  • Aquaculture. Design of immunological techniques to detect the presence of different marine organisms and toxins.
  • Immunotherapy: fully human monoclonal antibodies directed to human cells that could be useful in human therapy.
  • Nanomedicine: potential application of nanostructures in the biomedical field:
  • Tuberculosis.
  • Vaccines. Immune response to nanovaccines using different routes of administration (intranasal or intramuscular) on animals models.